Pancreatic Cancer Research

ResearcherWashington University in St. LouisNo recent work listed

Peter S. Goedegebuure

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5062157417. Sources: OpenAlex.

Their work

Papers
8 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
19
Papers, trials and grants by year

2011: 2 papers · 2012: 3 papers · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 8

  1. Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic du… Co-author DOI 10.1136/gutjnl-2017-313738↗
  2. Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134. Co-author DOI 10.1016/j.molonc.2014.03.005↗
  3. A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma. Co-author DOI 10.1007/s10637-012-9866-y↗
  4. Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth. Last author DOI 10.1007/s00262-011-1178-0↗
  5. Therapeutic targeting of pancreatic cancer utilizing sigma-2 ligands. Co-author DOI 10.1016/j.surg.2012.05.014↗
  6. Lysosomal membrane permeabilization is an early event in Sigma-2 receptor ligand mediated cell death in pancreatic cancer. Co-author DOI 10.1186/1756-9966-31-41↗
  7. Myeloid-derived suppressor cells: general characteristics and relevance to clinical management of pancreatic cancer. Co-author DOI 10.2174/156800911796191024↗
  8. Potential targets for pancreatic cancer immunotherapeutics. Last author DOI 10.2217/imt.11.10↗

Closest collaborators

The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. William G. Hawkins · 7 shared papers, 2011–2018 · strength 0.29
  2. John R. Hornick · 4 shared papers, 2012–2014 · strength 0.15
  3. David C. Linehan · 3 shared papers, 2011–2018 · strength 0.13
  4. William E. Gillanders · 3 shared papers, 2011–2018 · strength 0.13
  5. Dirk M. Spitzer · 3 shared papers, 2012–2014 · strength 0.12
  6. Booyeon Julia Han · 1 shared paper, 2018 · strength 0.07
  7. Timothy M. Nywening · 1 shared paper, 2018 · strength 0.07
  8. Dominic E. Sanford · 1 shared paper, 2018 · strength 0.07
  9. Roheena Z. Panni · 1 shared paper, 2018 · strength 0.07
  10. Ryan C Fields · 1 shared paper, 2018 · strength 0.07
  11. David G DeNardo · 1 shared paper, 2018 · strength 0.07
  12. Andrea Wang‐Gillam · 2 shared papers, 2011–2013 · strength 0.06
  13. Matthew R. Porembka · 2 shared papers, 2011–2012 · strength 0.06
  14. Lindzy F. Dodson · 1 shared paper, 2011 · strength 0.04
  15. Yassar M. Hashim · 1 shared paper, 2014 · strength 0.04
  16. Steven M. Sorscher · 1 shared paper, 2013 · strength 0.03
  17. Albert Craig Lockhart · 1 shared paper, 2013 · strength 0.03
  18. Carmen Abate · 1 shared paper, 2012 · strength 0.03
  19. Marcus Chuan Beng Tan · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.